Skip to main content

Table 2 Studies according to the type of intervention.

From: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis

Intervention
Study Intervention arm a Adjuvant therapies b
  Type of CHT N. Cycles R courses G-CSF AI prophylaxis RTX Other
Aviles 2007a CEOP 6 6 Discretionary NR No No
Aviles 2007b CEOP 6 6 Not reported
Aviles 2010 ESHAP 6 6 To all No No No
Buske 2009 CHOP 21 4 to 8 4 to 8 Not reported
Coiffier 2002 CHOP 21 8 8 Discretionary NR No No
Eve 2009 FC 8 8 NR PCP + VZV No No
Forstpointner 2004 FCM 4 4 Not reported
Habermann 2006 CHOP 21 6 to 8 4 to 5 Discretionary NR No M
Herold 2007 MCP 8 8 Not reported
Hiddemann 2005 CHOP 21 6 to 8 6 to 8 Not reported
Kaplan 2005 CHOP 21 3 to 6 3 to 6 To all PCP Discretionary M + ART
Lenz 2005 CHOP 21 6 6 Not reported
Marcus 2005 CVP 8 8 Not reported
Pfreundschuh 2008a CHOP 14 6 8 To all No No Pre-O
Pfreundschuh 2008b CHOP 14 8 8 To all No No Pre-O
Robak 2010 FC 6 6 Discretionary No No No
van Oers 2006 CHOP 21 3 to 6 3 to 6 Not reported
  1. Detailed protocol reported in additional file 6. a) This describes the type of therapy for intervention arm (patients in control arm received the same therapy apart from rituximab); b) This includes all reported non randomized therapies. AI prophylaxis = anti-infective prophylaxis; ART = antiretroviral therapy; C = chemotherapy; -CSF = granulocyte colony stimulating factor; GRTX = radio therapy; M = meningeal prophylaxis with methotrexate; N. cycles = number of cycles of scheduled therapy; NR = not reported; PCP = prophylaxis against P. jaroviecy; Pre-O = pre-treatment with single dose 1 mg vincristine and 100 mg prednisone orally for seven days; R course = number of cycles of scheduled rituximab course; VZV = prophylaxis against Varicella zoster virus